Journal
JOURNAL OF RHEUMATOLOGY
Volume 42, Issue 6, Pages 948-951Publisher
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.141163
Keywords
SYSTEMIC LUPUS ERYTHEMATOSUS; COMPLEMENT SYSTEM; LECTIN PATHWAY; INNATE IMMUNITY
Categories
Funding
- Danish Rheumatism Association
- Novo Nordisk Fonden [NNF13OC0007989] Funding Source: researchfish
Ask authors/readers for more resources
Objective. To examine whether proteins of the lectin pathway of the complement system are involved in systemic lupus erythematosus (SLE) pathogenesis. Methods. Using time-resolved immunofluorometric assays, plasma levels of mannan-binding lectin (MBL)-associated serine proteases 1 (MASP-1), MASP-2, MASP-3, MBL-associated protein of 19 kDa (MAp19), and MAp44 were determined in 58 patients with SLE and 65 healthy controls (HC). Results. Plasma concentrations in patients with SLE were higher than HC regarding MASP-1, MASP-3, and MAp44 (p < 0.0001, 0.0003, and 0.0013). Complement factor 3 correlated negatively and anti-dsDNA positively with levels of MAp19 (p = 0.0035, p = 0.0133). Conclusion. In SLE, plasma levels of MASP and MAp are altered and associated with SLE characteristics, supporting a role in SLE pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available